The synthesis and SAR of novel diarylsulfone 11beta-HSD1 inhibitors.
Article Details
- CitationCopy to clipboard
Yan X, Wang Z, Sudom A, Cardozo M, DeGraffenreid M, Di Y, Fan P, He X, Jaen JC, Labelle M, Liu J, Ma J, McMinn D, Miao S, Sun D, Tang L, Tu H, Ursu S, Walker N, Ye Q, Powers JP
The synthesis and SAR of novel diarylsulfone 11beta-HSD1 inhibitors.
Bioorg Med Chem Lett. 2010 Dec 1;20(23):7071-5. doi: 10.1016/j.bmcl.2010.09.097. Epub 2010 Sep 29.
- PubMed ID
- 20971000 [ View in PubMed]
- Abstract
In this communication, human 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitory activities of a novel series of diarylsulfones are described. Optimization of this series resulted in several highly potent 11beta-HSD1 inhibitors with excellent pharmacokinetic (PK) properties. Compound (S)-25 showed excellent efficacy in a non-human primate ex vivo pharmacodynamic model.
DrugBank Data that Cites this Article
- Binding Properties